Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 &mu;g pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study)

Original Research

Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 μg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study)

Total article views		HTML views	PDF downloads	Totals
5,661	Dovepress*	5,315+	220	5,535
	PubMed Central*	346	143	489
	Totals	5,661	363	6,024
*Since 8 July 2022